"Zeus" a new oral anticoagulant therapy dosing algorithm: A cohort study

Thrombosis Research

Volumn 128, Issue 4, 2011, Pages 325-330

  Cafolla, A ^a   Melizzi, R ^b   Baldacci, E ^a   Pignoloni, P ^a   Dragoni, F ^a   Campanelli, M ^a   Caraccini, R ^b   Foa R ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Siemens Healthcare Diagnostics   (Italy)

Author keywords

Computer assistance; Dosing therapy algorithm; Oral anticoagulant therapy

Indexed keywords

ACENOCOUMAROL; WARFARIN;

ADULT; ALGORITHM; ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; COHORT ANALYSIS; COMPUTER ASSISTED DRUG THERAPY; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; ORAL ANTICOAGULANT THERAPY; OUTPATIENT CARE; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; PROTHROMBIN TIME; RETROSPECTIVE STUDY; THROMBOEMBOLISM; TREATMENT INDICATION; TREATMENT PLANNING;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; ANTICOAGULANTS; BLOOD COAGULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DOSAGE CALCULATIONS; DRUG MONITORING; DRUG THERAPY, COMPUTER-ASSISTED; FEMALE; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; ITALY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTHROMBIN TIME; RETROSPECTIVE STUDIES; THROMBOSIS; TIME FACTORS;

EID: 80054963463     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.04.012     Document Type: Article

References (25)

1. J. Ansell, J. Hirsh, L. Poller, H. Bussey, A. Jacobson, and E. Hylek The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 3 suppl. 2004 S204 S233
2. T. Baglin Decentralised anticoagulant care J Clin Pathol 51 1998 89 90 (Pubitemid 28140719)
3. R.A. O'Reilly, and P.M. Aggeler Determinants of the response to oral anticoagulant drugs in man Pharmacol Rev 22 1 1970 35 96
4. P.J. Ryan, M. Gilbert, and P.E. Rose Computer control of anticoagulant dose for therapeutic management Br Med J 299 1989 1207 1209 (Pubitemid 19281174)
5. P.J. Wyld, D. West, and T.H. Wilson Computer dosing in anticoagulant clinics-the way forward? Clin Lab Haematol 10 1988 235 236
6. L. Poller, D. Wright, and M. Rowlands Prospective study of computer programs used for management of warfarin J Clin Pathol 46 1993 299 303 (Pubitemid 23138740)
7. W. Ageno, and A.G. Turpie A randomized comparison of a computer-based dosing program with a manual System to monitor oral anticoagulant therapy Thromb Res 91 1998 237 240 (Pubitemid 28451944)
8. L. Poller, C.R. Shiach, P.K. MacCallum, A.M. Johansen, A.M. Munster, and A. Magalhaes Multicentre randomised study of computerised anticoagulant dosage. European Concerted Action on Anticoagulation Lancet 352 1998 1505 1509 (Pubitemid 28512926)
9. C. Manotti, M. Moia, G. Palareti, V. Pengo, L. Ria, and E. Dettori Effect of computer-aided management on the quality of treatment in anticoagulant patients: a prospective, randomized multicenter trial of APROAT (Automated PRogram for Oral Anticoagulant Treatment) Haematologica 86 2001 1060 1070 (Pubitemid 33031872)
10. Y. Van Leeuwen, E.K. Rombouts, C.J. Kruithof, F.J.M. Van der Meer, and F.R. Rosendaal Improved control of oral anticoagulant dosing: a randomized controlled trial comparing two computer algorithms J Thromb Haemost 5 2007 1644 1649 (Pubitemid 47091405)
11. L. Poller, M. Keown, S. Ibrahim, G. Lowe, M. Moia, and A.G. Turpie An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs medical staff dosage J Thromb Haemost 6 2008 935 943 (Pubitemid 351689914)
12. F.R. Rosendaal, S.C. Cannegieter, F.J.M. van der Meer, and E. Briet A method to determine the optimal intensity of an oral anticoagulant therapy Thromb Haemost 69 1993 236 239 (Pubitemid 23069000)
13. J. Ansell, J. Hirsch, E. Hylek, A. Jacobson, M. Crowther, and G. Palareti Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-based clinical practice guidelines (8th Edition) Chest 133 2008 16S 98S
14. Y.K. Kim, R. Nieuwlaat, S.J. Connolly, S. Schulman, K. Meijer, and N. Raju Effect of a simple two-step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study J Thromb Haemost 8 2010 101 106
15. British Committee for Standards in Haematology Thrombosis and Haemostasis Task Force Guidelines on oral anticoagulation: third edition Br J Haematol 101 1998 374 387
16. L. Young, P. Ockelford, and P. Harper Audit of community-based anticoagulant monitoring in patients with thromboembolic disease: is frequent testing necessary? Intern Med J 34 2004 639 641 (Pubitemid 39587146)
17. R.E. Upshur, C. Papoushek, D. Macdonald, and G. Dantas Short report: managing anticoagulation. Comparison of results at three primary care centres Can Fam Physician 49 2003 181 184 (Pubitemid 36231006)
18. V.C. Pengo, C. Legnani, F. Noventa, G. Palareti ISCOAT(Italian Study Group on Complications of Oral Anticoagulant Therapy Oral anticoagulant therapy in patients with non rheumatic atrial fibrillation and risk of bleeding. A multicenter Inception Cohort study Thromb Haemost 85 2001 418 422 (Pubitemid 32233011)
19. A.M.M. Shepherd, D.S. Hewick, T.A. Moreland, and I.H. Stevenson Age as determinant of sensitivity to warfarin Br J Clin Pharmacol 4 1977 315 320
20. F. Kamali, T.I. Khan, B.P. King, R. Frearson, P. Kesteven, and P. Wood Contribution of age, body size and CYP2C9 genotype to anticoagulant response to warfarin Clin Pharm Ther 75 2004 204 212 (Pubitemid 38314870)
21. M.J. Reider, A.P. Reiner, B.F. Gage, D.A. Nickerson, C.S. Eby, and H.L. McLeod Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose N Engl J Med 14 2005 1745 1751
22. A.M. Holbrook, J.A. Pereira, R. Labiris, H. McDonald, J.D. Douketis, and M. Crowther Systematic overview of warfarin and its drug and food interactions Arch Intern Med 165 2005 1095 1106 (Pubitemid 40720733)
23. E.A. Sconce, T.I. Khan, H.A. Wynne, P. Avery, L. Monkhouse, and B.P. King The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen Blood 106 2005 2329 2333 (Pubitemid 41510803)
24. International Warfarin Pharmacogenetics Consortium, T.E. Klein, R.B. Altman, N. Eriksson, B.F. Cage, and S.E. Kimmel Estimation of the warfarin dose with clinical and pharmacogenetic data N Engl J Med 360 2009 753 764
25. E. Pasterkamp, C.J. Kruithof, F.J.M. Van Der Meer, F.R. Rosendaal, and P.M. Vanderschoot A model-based algorithm for the monitoring of long-term anticoagulation therapy J Thromb Haemost 3 2005 915 921 (Pubitemid 41632819)